
Alert: Major Price Advance (10/2/25)-Neoleukin Therapeutics Inc (NASDAQ: NGNE).
Neoleukin Therapeutics Inc (NASDAQ: NGNE) stock enjoyed a major increase of 16.7% on 10/2/25. The shares closed at $20.98. Moreover, this advance was accompanied by exceptionally high trading volume at 360% of normal. Relative to […]